Search results for: Baylor University Medical Center

J. Sebastian Danobeitia, MD, PhD, joins Baylor Annette C. and Harold C. Simmons Transplant Institute

J. Sebastian Danobeitia, MD, PhD, has joined the medical staff at Baylor Annette C. and Harold C. Simmons Transplant Institute. An abdominal transplant surgeon specializing in liver, kidney, pancreas and islet transplantation, Dr. Danobeitia is part of the transplant team at Baylor University Medical Center at Dallas, part of Baylor Scott & White Health.

Read more

Baylor Scott & White has substantial presence at AASLD The Liver Meeting 2023

Physician-researchers from Baylor Scott & White Health played a prominent role at the American Association for the Study of Liver Disease (AASLD) The Liver Meeting 2023, held Nov. 10-14 in Boston. They presented the latest insights from one of the largest multispecialty transplant centers in the nation: Baylor Scott & White Annette C. and Harold C. Simmons Transplant Institute in Dallas.

Read more

Newly approved medication routinely prescribed for hepatorenal syndrome

Until recently, there was no FDA-approved treatment in the United States for hepatorenal syndrome, a major complication of advanced liver disease. Patients with hepatorenal syndrome develop acute kidney failure, and often require dialysis. After more than a decade of research, in September 2022 the FDA granted approval to terlipressin, a medication that can reverse kidney failure in these patients, quickly establishing terlipressin as the routinely prescribed medication.

Read more